BIB vs. OILK
BIB (ProShares Ultra Nasdaq Biotechnology) and OILK (ProShares K-1 Free Crude Oil Strategy ETF) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while OILK is a Oil & Gas fund tracking the Bloomberg Commodity Balanced WTI Crude Oil Index. Both are passively managed. Over the past 5 years, BIB returned -0.11%/yr vs 17.28%/yr for OILK. At a 0.07 correlation, their price movements are largely independent. BIB charges 0.95%/yr vs 0.68%/yr for OILK.
Performance
BIB vs. OILK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 4.15% return, which is significantly lower than OILK's 61.09% return.
BIB
- 1D
- 4.68%
- 1M
- 0.28%
- YTD
- 4.15%
- 6M
- 1.65%
- 1Y
- 85.17%
- 3Y*
- 16.12%
- 5Y*
- -0.11%
- 10Y*
- 5.85%
OILK
- 1D
- -1.91%
- 1M
- -2.15%
- YTD
- 61.09%
- 6M
- 56.40%
- 1Y
- 56.95%
- 3Y*
- 18.39%
- 5Y*
- 17.28%
- 10Y*
- —
BIB vs. OILK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 4.15% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
OILK ProShares K-1 Free Crude Oil Strategy ETF | 61.09% | -11.86% | 8.18% | -0.97% | 27.57% | 63.71% | -61.09% | 30.48% | -20.40% | 2.82% |
Correlation
The correlation between BIB and OILK is -0.26, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.03 |
Correlation (All Time) Calculated using the full available price history since Sep 29, 2016 | 0.07 |
The correlation between BIB and OILK shifts across timeframes, from -0.26 (1 year) to 0.07 (all time), reflecting how their relationship changes across market environments.
BIB vs. OILK - Sectors Allocation Comparison
Sectors
BIB
OILK
Healthcare
-
Financial Services
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BIB
OILK
-
Financial Services
BIB
OILK
-
Basic Materials
BIB
-
OILK
-
Communication Services
BIB
-
OILK
-
Consumer Cyclical
BIB
-
OILK
Consumer Defensive
BIB
-
OILK
-
Energy
BIB
-
OILK
-
Industrials
BIB
-
OILK
-
Real Estate
BIB
-
OILK
-
Technology
BIB
-
OILK
-
Utilities
BIB
-
OILK
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. OILK — Risk / Return Rank
BIB
OILK
BIB vs. OILK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares K-1 Free Crude Oil Strategy ETF (OILK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BIB | OILK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.16 | ||
| Sortino ratioReturn per unit of downside risk | +0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.33 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 5.06 | 3.30 | +1.76 |
| Martin ratioReturn relative to average drawdown | 16.05 | 6.67 | +9.38 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BIB | OILK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.15 | 1.99 | +0.16 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.00 | 0.58 | -0.58 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.13 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | 0.11 | +0.23 |
Drawdowns
BIB vs. OILK - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum OILK drawdown of -83.76%. Use the drawdown chart below to compare losses from any high point for BIB and OILK.
Loading charts...
Drawdown Indicators
| BIB | OILK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -83.76% | +16.52% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -17.35% | +0.43% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -23.42% | -21.88% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -34.69% | -31.17% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | — | — |
Current DrawdownCurrent decline from peak | -23.43% | -5.49% | -17.94% |
Average DrawdownAverage peak-to-trough decline | -32.74% | -32.60% | -0.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.32% | 8.57% | -3.25% |
Volatility
BIB vs. OILK - Volatility Comparison
ProShares Ultra Nasdaq Biotechnology (BIB) has a higher volatility of 14.70% compared to ProShares K-1 Free Crude Oil Strategy ETF (OILK) at 10.52%. This indicates that BIB's price experiences larger fluctuations and is considered to be riskier than OILK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | OILK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.70% | 10.52% | +4.18% |
Volatility (6M)Calculated over the trailing 6-month period | 30.88% | 23.32% | +7.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 39.80% | 28.82% | +10.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.59% | 30.13% | +13.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.51% | 35.97% | +10.54% |
BIB vs. OILK - Expense Ratio Comparison
BIB has a 0.95% expense ratio, which is higher than OILK's 0.68% expense ratio.
Dividends
BIB vs. OILK - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.59%, less than OILK's 8.34% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.59% | 0.77% | 1.69% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OILK ProShares K-1 Free Crude Oil Strategy ETF | 8.34% | 4.79% | 3.11% | 5.80% | 17.32% | 68.82% | 0.13% | 0.94% | 0.58% | 6.17% |
Frequently Asked Questions
BIB and OILK have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIB has higher volatility (14.70%) compared to OILK (10.52%). In terms of maximum drawdown, BIB dropped -67.24% vs OILK's -83.76%.
On 5-year performance, OILK leads with 17.28% vs -0.11% for BIB. On fees, OILK is cheaper at 0.68% per year. On volatility, OILK has been the lower-risk option at 10.52%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, OILK has performed better with a 17.28% return vs -0.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
OILK is cheaper with a 0.68% expense ratio, compared with 0.95% for BIB.
OILK has the higher dividend yield at 8.34%, compared with 0.59% for BIB.
BIB is categorized as Leveraged Equities, while OILK is Oil & Gas. BIB tracks NASDAQ Biotechnology Index (200%), while OILK tracks Bloomberg Commodity Balanced WTI Crude Oil Index. Their fees differ too: 0.95% for BIB and 0.68% for OILK.
BIB currently has the higher Sharpe Ratio (2.15 vs 1.99), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and OILK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer